U.S. Healthtech Stock News

NYSE:BSM
NYSE:BSMOil and Gas

Black Stone Minerals (BSM) Bets On Gas Growth, Is The Stock Still Cheap?

Black Stone Minerals (BSM) has drawn investor attention after recent trading left the stock near $13.68, with returns relatively flat over the past month but lower over the past 3 months and week. See our latest analysis for Black Stone Minerals. At around $13.68, Black Stone Minerals’ recent share price has drifted lower over the past week and quarter, while its 1 year and multi year total shareholder returns remain positive. This suggests momentum has cooled recently compared with longer...
NYSE:TRLV
NYSE:TRLVPharmaceuticals

Trulieve Cannabis (TRLV) Could Be 51% Undervalued After Georgia Medical Cannabis Expansion

Trulieve Cannabis (TRLV) stock is in focus after Georgia expanded its medical cannabis program under Senate Bill 220, allowing flower and vaporization products and broadening patient access across the state. See our latest analysis for Trulieve Cannabis. Trulieve Cannabis shares have been volatile around the Georgia news. The latest share price is $9.54 after a 1 day share price return that declined 2.95%. However, a 90 day share price return of 57.95% and a 1 year total shareholder return of...
NYSE:HCA
NYSE:HCAHealthcare

Is HCA Healthcare (HCA) A Bargain As Russell Index Removals Reshape Ownership?

HCA Healthcare (HCA) has just been removed from several major Russell growth indexes after the latest rebalancing, a technical shift that primarily affects who owns the stock rather than how its hospitals operate. See our latest analysis for HCA Healthcare. Index removals have come after a period where HCA Healthcare’s share price return has fallen 16.4% year to date and 16.7% over three months, even as its 5 year total shareholder return of 89.04% points to a much stronger longer run...
NYSE:SYF
NYSE:SYFConsumer Finance

Synchrony Financial (SYF) Leans Into Digital Leadership As Undervalued Narrative Stays In Focus

Synchrony Financial (SYF) has reshaped its senior leadership around technology and digital platforms, promoting Carol Juel to lead its Digital platform and elevating Florin Arghirescu to Executive Vice President and Chief Technology Officer. See our latest analysis for Synchrony Financial. The leadership reshuffle comes as Synchrony Financial’s share price stands at $76.77, with a 30-day share price return of 8.40% and a 90-day share price return of 12.20%. The 3-year total shareholder return...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Is Up 6.9% After Promising Phase 2 Atumelnant And Paltusotine Data Release - Has The Bull Case Changed?

Crinetics Pharmaceuticals recently presented Phase 2 TouCAHn data showing atumelnant reduced glucocorticoid doses while maintaining androgen control in classic congenital adrenal hyperplasia, and shared two-year PALSONIFY (paltusotine) data in acromegaly indicating maintained disease control and tolerability, while also scheduling its second-quarter 2026 earnings release and business update call for August 4, 2026. Together, these clinical updates highlight Crinetics’ progress in rare...
NYSE:RRX
NYSE:RRXElectrical

What Regal Rexnord (RRX)'s Hedge Fund Backing Amid Insider Selling Means for Shareholders

In recent days, Kerrisdale Capital announced a long position in Regal Rexnord, praising its portfolio overhaul following the acquisitions of Rexnord’s Process & Motion Control business and Altra Industrial Motion, and highlighting its push into data center power equipment modules (ePODs). An interesting angle is that this upbeat external endorsement arrived alongside a period of significant insider share sales and valuation metrics suggesting the stock is trading well above some intrinsic...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Supply Chain Stocks Facing A Pricing Power Test

Supply chain disruptions are doing more than keeping shelves patchy; they are reshaping pricing power across logistics, shipping, ports, and storage. When goods are harder to replace, companies that move and manage them can sometimes set terms instead of just accepting them, while weaker operators risk being squeezed by higher costs and lost volumes. This article looks at three stocks from a Supply Chain Infrastructure and Logistics Companies screener that are closely tied to these pressures...
NYSE:SUI
NYSE:SUIResidential REITs

How Index Removal And A New General Counsel At Sun Communities (SUI) Has Changed Its Investment Story

In late June 2026, Sun Communities, Inc. was removed from several Russell Growth indices after recent portfolio changes, while also appointing Ileana McAlary as General Counsel, Executive Vice President, and Secretary effective June 29, 2026. This combination of index removals and a senior legal leadership hire highlights how Sun Communities is reshaping its profile and governance following its UK exit. Next, we’ll examine how Sun Communities’ removal from multiple Russell Growth benchmarks...
NYSE:APO
NYSE:APODiversified Financial

How Apollo’s Removal from Russell Growth Indices Will Impact Apollo Global Management (APO) Investors

Apollo Global Management, Inc. was recently removed from several major Russell Growth benchmarks, including the Russell 1000, 200, 3000, and 3000E Growth indices, prompting index-tracking funds to adjust their holdings. This index removal highlights how benchmark reclassifications can reshape a company’s investor base and trading patterns, especially for large alternative asset managers. We’ll now explore how Apollo’s removal from key Russell Growth indices could influence its existing...
NYSE:CON
NYSE:CONHealthcare

Why Concentra (CON) Is Up 5.6% After Russell Shift And New Clinic Opening – And What's Next

In late June 2026, Concentra Group Holdings Parent, Inc. (NYSE: CON) was removed from several Russell value benchmarks but added to the Russell 2000 Growth-Defensive and Russell 2000 Defensive Indexes, while also opening its first occupational health medical center in Goodyear, Arizona, its 17th location in the state. This combination of index reclassification toward growth-defensive exposure and continued clinic expansion underscores how Concentra is being repositioned by the market as a...
NYSE:MHO
NYSE:MHOConsumer Durables

M/I Homes (MHO) Could Be 22% Undervalued As Investors Revisit Its Housing Narrative

Why M/I Homes Stock Is Drawing Fresh Attention M/I Homes (MHO) is back on investor radars after recent share price moves, with the stock showing varied short term returns alongside longer term total returns that some investors are reassessing against its current valuation. See our latest analysis for M/I Homes. Against this backdrop, M/I Homes has seen its share price pull back about 2.6% over the last day and 1.4% over the past week, even after a 30 day share price return of 13.7% and a 1...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

CUSMA Uncertainty Makes These 3 U.S. Manufacturing Stocks Worth A Closer Look

Trade friction between the U.S., Canada and Mexico is back in focus as the future of CUSMA turns uncertain, and that has direct implications for stocks tied to cross border supply chains. While many manufacturers rely heavily on tariff friendly trade, some U.S. domestic producers have business models that may be less exposed to potential changes in the agreement. This article looks at how that news backdrop might matter for your portfolio and highlights 3 U.S. domestic manufacturing stocks...
NasdaqGS:FA
NasdaqGS:FAProfessional Services

First Advantage (FA) Beats On Earnings And Joins S&P SmallCap 600, Is The Upside Priced In?

First Advantage (FA) drew fresh attention after reporting Q1 2026 earnings that surpassed analyst expectations, along with confirmation it will join the S&P SmallCap 600 index, a combination that put recent share gains into focus. See our latest analysis for First Advantage. Over the past year, First Advantage has seen strong momentum, with the share price delivering a 68.25% 90 day return and a 32.60% year to date share price return, while the 1 year total shareholder return stands at...
NasdaqGM:PTGX
NasdaqGM:PTGXBiotechs

The Bull Case For Protagonist Therapeutics (PTGX) Could Change Following Rusfertide Review Optimism And New Hires – Learn Why

In late June 2026, Protagonist Therapeutics granted stock-based inducement awards to three new employees and received upbeat analyst commentary emphasizing upcoming PN-881 data and the Rusfertide regulatory decision. This combination of fresh talent incentives and growing external confidence in the company’s pipeline has sharpened investor focus on its development and commercialization plans. With this backdrop, we'll examine how enthusiasm around Rusfertide’s regulatory review shapes...
NYSE:ABX
NYSE:ABXInsurance

Abacus Global Management (ABX) Could Be 6% Overvalued As Legal Win Lifts Shares

Abacus Global Management (ABX) drew investor attention after its stock gained 7.3% in the latest session, following a federal court decision that denied Coventry First's motion to dismiss Abacus's defamation lawsuit. See our latest analysis for Abacus Global Management. That legal win slots into a strong recent run for Abacus Global Management, with a 30 day share price return of 29.06% and a 1 year total shareholder return of 125.86%, suggesting momentum has been building for some time. If...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Penguin Solutions (PENG) Could Be 80% Overvalued As AI Factory News Draws Growth Investors

Why Penguin Solutions Is Suddenly On Growth Investors' Radar Penguin Solutions (PENG) has quickly drawn attention after being reclassified into several Russell growth indices, paired with an upgraded ClusterWareAI platform and a new NVIDIA AI Factory Specialized Partner designation. This combination links the stock directly to indexed growth capital, AI infrastructure software and validated ties to NVIDIA based AI factories, giving investors a fresh context for evaluating Penguin Solutions'...
NYSE:ECG
NYSE:ECGConstruction

Does Everus Construction Group’s (ECG) Russell Index Debut Reveal a Shifting Institutional Demand Story?

On 27 June 2026, Everus Construction Group, Inc. (NYSE: ECG) was added to several Russell Growth benchmarks, including the Russell 1000, 3000, 3000E, 2500, Midcap, and Small Cap Composite Growth Indexes. This broad index inclusion can expand Everus Construction Group’s presence in benchmark-driven portfolios, potentially increasing its shareholder base and influencing trading liquidity over time. Next, we’ll examine how Everus Construction Group’s addition to multiple Russell Growth indexes...
NYSE:UPS
NYSE:UPSLogistics

United Parcel Service (UPS) Joins Defensive Indexes, Is The Stock Still Cheap?

United Parcel Service (UPS) is drawing fresh attention after being added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index, a move that can influence demand from index-tracking funds. See our latest analysis for United Parcel Service. The index additions arrive as momentum in United Parcel Service’s share price has been building, with a 1-day share price return of 1.90%, 7-day return of 3.20% and 90-day return of 11.57%, while the 1-year total shareholder...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

3 Quality Stocks Built For A Pricey Market

With valuations stretched on popular benchmarks and volatility picking up, many investors are asking whether their portfolios are built on hype or on substance. Elevated measures such as the Shiller CAPE Ratio and the Buffett indicator point to a market where quality and resilience matter more than ever. This article looks at three stocks from our Quality Stocks screener that are closely exposed to the current market backdrop, focusing on balance sheet strength, earnings consistency, and risk...
NYSE:CXT
NYSE:CXTElectronic

Crane NXT (CXT) Joins Smaller Russell Indices, Is It Still 22% Undervalued?

Crane NXT (CXT) is shifting across the Russell index family, exiting several large and mid cap indices while entering the Russell 2000, including its value and defensive benchmarks. This change can reshape institutional flows. See our latest analysis for Crane NXT. Crane NXT’s recent index reshuffle comes after a period of strong short term momentum, with a 30 day share price return of 42.67% and a 90 day share price return of 29.29%. This contrasts with a declining 1 year total shareholder...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Does Monolithic Power Systems' (MPWR) Shift Into Russell Large-Cap Indices Redefine Its AI Data Center Story?

In late June 2026, Monolithic Power Systems, Inc. was added to the Russell Top 200 Index and Russell Top 200 Growth Benchmark while being removed from the Russell Midcap and Russell Midcap Growth indices, reflecting its shift into a larger-cap peer group. This index migration coincides with increased attention on the company’s power solutions for AI data centers, which are drawing more institutional investor interest. Next, we’ll examine how this move into Russell’s large-cap indices,...
NYSE:WAL
NYSE:WALBanks

How Investors Are Reacting To Western Alliance (WAL) Topping Forbes’ 2026 Best-in-State Banks List

In June 2026, Western Alliance Bank was named to the Forbes 2026 America’s Best-in-State Banks list, ranking first in Arizona and standing as the only Arizona-based bank included. This recognition, based on customer surveys and online reviews of trust, service quality, digital tools, and financial advice, reinforces Western Alliance’s reputation strength in its home market. Next, we’ll explore how this trust-focused Forbes recognition could influence Western Alliance’s investment narrative...
NasdaqGS:CATY
NasdaqGS:CATYBanks

What Cathay General Bancorp (CATY)'s Zacks Upgrade and Momentum Shift Means For Shareholders

In late June 2026, Cathay General Bancorp received an upgrade to a Zacks Rank #2 (Buy), supported by upward revisions to its earnings estimates and an A Momentum Style Score based on relatively strong recent performance versus peers. This combination of improved earnings expectations and positive momentum signals a shift in analyst sentiment that could influence how investors view the bank’s risk‑reward trade‑off. We’ll now examine how this earnings estimate upgrade and stronger momentum...
NYSE:ASB
NYSE:ASBBanks

Higher For Longer Rates Could Lift These US Bank Stocks

With the Federal Reserve signaling a tougher stance on inflation and markets weighing the risk of higher-for-longer interest rates, large US bank stocks are back in focus. Higher borrowing costs can reshape lending margins, credit demand, and investor expectations in different ways. This article looks at 3 US large cap bank stocks from our screener that are closely tied to the latest Fed commentary and inflation data. It aims to help you think through where the current macro backdrop might...